- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03175770
Feasibility of Radiofrequency Resection in Oropharyngeal Tumor Surgery
In the last years radiofrequency resection has become a frequent method in surgical subspecialties. Although many departments are using this method for the resection of Tumor in the oropharynx, there is no study so far which describes feasibility and safety.
Goal of this study is to show feasibility and safety of Radiofrequency Resection in Oropharyngeal Tumor Surgery.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
In the last years radiofrequency resection has become a frequent method in surgical subspecialties. Although many departments are using this method for the resection of Tumor in the oropharynx, there is no study so far which describes feasibility and safety.
Goal of this study is to show feasibility and safety of Radiofrequency Resection in Oropharyngeal Tumor Surgery.
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
Bayern
-
Munich, Bayern, Tyskland, 81675
- Department of Ear Nose Throat
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- 18 years and older benign or malign tumor of the oropharynx tumor must be resectable transorally
Exclusion Criteria:
- Prior radiotherapy or chemotherapy
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
---|---|
Patients with benign or malign tumor in the oropharynx
Patient of 18 years and older with benign or malign tumor in the oropharynx.
The resection is done transorally by radiofrequency
|
Patient of 18 years and older with benign or malign tumor in the oropharynx.
The resection is done transorally by radiofrequency
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
total blood loss,
Tidsramme: intraoperative
|
assessing the blood loss by measuring blood in the suction
|
intraoperative
|
tissuesticking
Tidsramme: intraoperative
|
tissuesticking by physician global assessment scale from 1 - 6
|
intraoperative
|
coagulation
Tidsramme: intraoperative
|
coagulation by physician global assessment scale from 1 - 6,
|
intraoperative
|
Duration of Operation
Tidsramme: intraoperative
|
measuring Duration of Operation in minutes
|
intraoperative
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Zone of coagulation
Tidsramme: within one month after the operation
|
Zone of coagulation to assess the tissue damage by radiofrequency by a scale 1 - 6,
|
within one month after the operation
|
postoperative parameters
Tidsramme: within one month after the operations
|
woundhealing by Parameters normal, delayed, infection;
|
within one month after the operations
|
postoperative pain
Tidsramme: within one month after the operations
|
postoperative pain by visual analog scale from 0 -10,
|
within one month after the operations
|
accuracy of section
Tidsramme: within one month after the operations
|
accuracy of section assessed by a scale from 1 - 6
|
within one month after the operations
|
status of resection
Tidsramme: within one month after the operations
|
assessment of status of resection by assessing the margins of resection for Tumor scale from 1 - 6,
|
within one month after the operations
|
postoperative dysfunctions by descriptive name of scale
Tidsramme: within one month after the operations
|
postoperative dysfunctions by descriptive scale from 1 -10
|
within one month after the operations
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Clemens Heiser, MD, department for ENT, Klinikum Rechts der Isar der Technischen Universität München, Ismaninger Straße 22, 81675 München, Germany
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 381/14
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Radiofrequency Resection
-
Seoul National University HospitalRekrutteringLARS - Low Anterior Resection SyndromeKorea, Republikken
-
Ankara UniversityAarhus University Hospital; Dokuz Eylul University; Lokman Hekim ÜniversitesiAfsluttetLARS - Low Anterior Resection Syndrome
-
HEM Pharma Inc.Premier Research Group plcIkke rekrutterer endnuLARS - Low Anterior Resection Syndrome
-
KU LeuvenUniversitaire Ziekenhuizen KU LeuvenIkke rekrutterer endnuEndetarmskræft | LARS - Low Anterior Resection Syndrome
Kliniske forsøg med transoral radiofrequency Resection in Oropharyngeal Tumor Surgery
-
Sohag UniversityIkke rekrutterer endnu